Literature DB >> 22309306

Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor.

Eva-Maria Schmidt1, Shuchen Gu, Vasileia Anagnostopoulou, Konstantinos Alevizopoulos, Michael Föller, Florian Lang, Christos Stournaras.   

Abstract

The serum- and glucocorticoid-dependent kinases 1-3 (SGK1-3) are downstream effectors of phosphatidylinositol 3-kinases, implicated in various cell responses including colon cancer tumorigenesis in mice. Here, we investigated the role of SGK1 in the regulation of cell motility. Using Caco-2 colon tumor and HEK293 embryonic kidney cells, we report that transfection with the constitutively active SGK1 mutant (SGK1-SD) significantly enhanced cell motility. The cell-adhesion protein vinculin was effectively dephosphorylated in SGK1-SD-transfected cells. Treatment of the cells with phosphatase inhibitors restored vinculin phosphorylation and inhibited cell migration, indicating a significant role for vinculin phosphorylation in SGK1-induced motility. SGK1-SD-enhanced cell motility was inhibited by activation of membrane androgen-binding sites (mAR) via testosterone-conjugates in both cell lines, whereas intracellular androgen receptor (iAR)-silencing and flutamide treatment revealed that these effects were clearly independent of the interaction of SGK1 with the classical androgen receptors (iAR). More importantly, mAR activation restored vinculin phosphorylation in SGK1-SD-transfected cells, whereas silencing of vinculin fully reversed the mAR-induced inhibition of the migratory capacity, implying that this protein is directly involved in cell motility regulation by SGK1 and mAR. This study indicates for the first time that SGK1 regulates cell migration via vinculin dephosphorylation, a mechanism that is controlled by mAR function.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309306     DOI: 10.1111/j.1742-4658.2012.08515.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  12 in total

1.  Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells.

Authors:  Guilai Liu; Sabina Honisch; Guoxing Liu; Sebastian Schmidt; Stavros Pantelakos; Saad Alkahtani; Mahmoud Toulany; Florian Lang; Christos Stournaras
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Testosterone induced apoptosis in colon cancer cells is regulated by PI3K/Rac1 signaling.

Authors:  Saad Alkahtani
Journal:  Asian J Androl       Date:  2013-06-17       Impact factor: 3.285

3.  Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion.

Authors:  Evan J Greenawalt; Mick D Edmonds; Neha Jain; Clare M Adams; Ramkrishna Mitra; Christine M Eischen
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

Review 4.  Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.

Authors:  Robert J Handa; Michael J Weiser
Journal:  Front Neuroendocrinol       Date:  2013-11-16       Impact factor: 8.606

5.  Ablation of SGK1 impairs endothelial cell migration and tube formation leading to decreased neo-angiogenesis following myocardial infarction.

Authors:  Elham Zarrinpashneh; Tommaso Poggioli; Padmini Sarathchandra; Jonas Lexow; Laurent Monassier; Cesare Terracciano; Florian Lang; Federico Damilano; Jessica Q Zhou; Anthony Rosenzweig; Nadia Rosenthal; Maria Paola Santini
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

6.  Up-regulation of Orai1 expression and store operated Ca(2+) entry following activation of membrane androgen receptors in MCF-7 breast tumor cells.

Authors:  Guilai Liu; Sabina Honisch; Guoxing Liu; Sebastian Schmidt; Saad Alkahtani; Abdullah A AlKahtane; Christos Stournaras; Florian Lang
Journal:  BMC Cancer       Date:  2015-12-21       Impact factor: 4.430

7.  Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.

Authors:  Shuye Tian; Xuemin Wang; Christopher G Proud
Journal:  Oncotarget       Date:  2017-07-11

Review 8.  The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star.

Authors:  Ruizhe Zhu; Gang Yang; Zhe Cao; Kexin Shen; Lianfang Zheng; Jianchun Xiao; Lei You; Taiping Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-07-15       Impact factor: 8.168

9.  Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local control.

Authors:  Henrik O Berdel; Hongyu Yin; Jun Yao Liu; Karolina Grochowska; Christopher Middleton; Nathan Yanasak; Rafik Abdelsayed; Wolfgang E Berdel; Mahmood Mozaffari; Jack C Yu; Babak Baban
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT.

Authors:  Weiwei Liu; Xuchu Wang; Yiyun Wang; Yibei Dai; Yiyi Xie; Ying Ping; Binbin Yin; Pan Yu; Zhenping Liu; Xiuzhi Duan; Zhaoping Liao; Yuhua Chen; Chunhua Liu; Xiang Li; Zhihua Tao
Journal:  J Exp Clin Cancer Res       Date:  2018-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.